Ultragenyx Pharmaceutical Inc. with ticker code (RARE) have now 19 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between 140 and 48 suggesting an average Analsyt target price of $90.05. Now with the previous closing price of $49.90 this now indicates there is a potential upside of 80.5%. The day 50 moving average is $42.19 and the 200 moving average now moves to $42.82. The market cap for the company is 3.59B. The stock price for Skyline Champion Corporation is 50.71 USD
The potential market cap would be $6,480,357,363 based on the market consensus.
USD
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of -, revenue per share of 5.47 and a -30.1% return on assets.
